Xencor Inc.

S&P 500

XNCR/Healthcare · Biotechnology/NASDAQ

Stock Price

$14.74

Stock Price$14.74MCap1.0BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

N/A/ 100

Dividend Safety Rating

XNCR does not currently pay a dividend. The Dividend Safety Rating is not applicable for non-dividend stocks.

About Xencor Inc.

Xencor Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibodies and antibody therapeutics. Powered by its proprietary XmAb protein engineering platform, Xencor designs drug candidates optimized for enhanced efficacy and safety profiles to treat patients with cancer, asthma, allergic diseases, and autoimmune conditions. The company maintains a broad pipeline, with more than 20 programs in clinical testing and numerous others in preclinical development. Notably, three XmAb medicines are currently marketed by strategic partners, enabling milestone payments, royalties, and collaborative advancements. Xencor focuses on expanding the therapeutic potential of antibodies through innovative protein engineering from the ground up, addressing severe diseases where conventional treatments fall short. Founded in 1997 and headquartered in Monrovia, California, Xencor plays a key role in the biotechnology sector by advancing next-generation biologics for unmet medical needs.

Dividend Overview

Dividend Yield

0.00%

Annual Dividend

$0.00

Frequency

N/A

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$6.92 - $18.69

Earnings & Profitability

XNCR earnings per share and net profit margin

Key Dates

Next Ex-Dividend Date

—

Next Payment Date

—

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

XNCR Dividend Calculator

Number of Shares

Total Investment

$1,474.00

Annual Income

$0.00

Quarterly Income

$0.00

Monthly Income

$0.00

Frequently Asked Questions

What is XNCR's current dividend yield?

Xencor Inc. (XNCR) currently has a dividend yield of 0.00%, based on a stock price of $14.74 and an annual dividend of $0.00.

When is XNCR's next dividend payment date?

XNCR's next ex-dividend date is — and the next payment date is —. You must own the stock before the ex-dividend date to receive the upcoming payment.

How much does XNCR pay in dividends per year?

Xencor Inc. pays dividends unknown. Annual dividend data is not yet available.

Has XNCR been increasing its dividend?

Xencor Inc. has grown its dividend at a 5-year CAGR of —.

Is XNCR's dividend safe?

Xencor Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.

How is XNCR's Dividend Safety Rating calculated?

The Dividend Safety Rating evaluates Xencor Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track XNCR Dividends with OnlyDividends

What will XNCR actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.